GlaxoSmithKline
GSK
$44.77
Share price
1.70%
Change (1 day)
32.46%
Change (1 year)
Categories
GlaxoSmithKline (GSK) - Net assets
Net assets on the balance sheet as of March 2024 : $16.71 B
According to GlaxoSmithKline's latest financial reports the company has $16.71 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $16.28 B | 33.11% |
| 2022-12-31 | $12.23 B | -57.52% |
| 2021-12-31 | $28.80 B | 1.57% |
| 2020-12-31 | $28.36 B | 17.83% |
| 2019-12-31 | $24.07 B | 416.44% |
| 2018-12-31 | $4.66 B | -1.16% |
| 2017-12-31 | $4.71 B | -23.06% |
| 2016-12-31 | $6.12 B | -53.42% |
| 2015-12-31 | $13.15 B | 71.2% |
| 2014-12-31 | $7.68 B | -40.36% |
| 2013-12-31 | $12.88 B | 18.34% |
| 2012-12-31 | $10.88 B | -20.47% |
| 2011-12-31 | $13.69 B | -8.98% |
| 2010-12-31 | $15.04 B | -13.46% |
| 2009-12-31 | $17.38 B | 42.59% |
| 2008-12-31 | $12.19 B | -38.13% |
| 2007-12-31 | $19.70 B | 4.02% |
| 2006-12-31 | $18.94 B | 45.6% |
| 2005-12-31 | $13.01 B | 10.24% |
| 2004-12-31 | $11.80 B | -21.96% |
| 2003-12-31 | $15.12 B | 60.23% |
| 2002-12-31 | $9.43 B | -12.02% |
| 2001-12-31 | $10.72 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $39.75 B | 137.81% | 🇨🇭 Switzerland |
 Pfizer PFE | $92.55 B | 453.65% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 391.71% | 🇫🇷 France |
 Merck MRK | $40.42 B | 141.80% | 🇺🇸 USA |
 AstraZeneca AZN | $37.50 B | 124.32% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $7.54 B | -54.88% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.61 B | -96.30% | 🇺🇸 USA |